Herein, we proposed that tetramer PKM2 inhibition could reduce ATP and lactate production, thereby remodeling the tumor immune microenvironment, as well as deactivating TGF-β pathway and blocking the nuclear ectopic of PKM2 to reverse EMT. Here, PKM is linked to neoplasm.